Genesis HealthCare (GEN) Tops Q3 EPS by 12c; Guidance Reaffirmed

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. S
10. COF

Go back to Genesis HealthCare (GEN) Tops Q3 EPS by 12c; Guidance Reaffirmed

Genesis HealthCare Reports Third Quarter 2016 Results

November 3, 2016 4:02 PM EDT

Announces Planned Divestiture of Facilities in Eight States to Focus on Core Markets

Recently Announced New Leases Reduce Prior Lease Obligation by $440 Million through January 2032 Third Quarter EBITDA Meets First Call Consensus Estimate

KENNETT SQUARE, Pa., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United States, today announced operating results for the third quarter ended September 30, 2016. 

... More

Genmab Announces Financial Results for the First Nine Months of 2016 and Improves 2016 Financial Guidance

November 2, 2016 12:02 PM EDT

November 2, 2016; Copenhagen, Denmark;

Interim Report for First Nine Months Ended September 30, 2016

Highlights

Net Sales of DARZALEX® (daratumumab) by Janssen for the first nine months of 2016 were USD 372 million, resulting in royalty income of USD 45 million (DKK 298 million)... More